Categories
Press Release

Inaedis announces investment from Roadrunner Venture Studios

Deep tech venture studio joins Princeton Innovation Center in supporting powderized vaccine company.

PRINCETON, NEW JERSEY (February 27, 2024) — Inaedis, Inc., a new platform biotechnology company, closed a pre-seed investment from Roadrunner Venture Studios, the premier deep tech venture studio in the United States. The investment will allow the company to continue to develop its first product, hire into critical roles, and sign its first customers. 

As a studio company, Inaedis will participate in Roadrunner’s world-class company building process.

“Roadrunner will unlock enormous value for our mission to eliminate the cold chain from pharmaceutical manufacturing and distribution,” said Inaedis founder and CEO, Dr. Maksim Mezhericher. “Our team will need the best support on offer to get where we want to go. Roadrunner offers us exactly that.”

Inaedis will have access to a suite of services, including product development, veteran CEO and entrepreneurship coaching, an in-house Head of Talent and veteran recruiter, office space, as well as operations and fundraising support. 

“Dr. Mezhericher and his team are visionaries building a breakthrough product that will change the world,” said Roadrunner CEO Adam Hammer. “That is Roadrunner’s ethos: We are in the business of backing leaders who use their gifts to alter the future for the better. Inaedis’ efforts to powderize biologics and other life-saving drugs will radically transform development, delivery, and distribution, building a disruptive company and saving countless lives.”

Inaedis, Inc.

Inaedis, Inc. is a spin-out company from Princeton University developing a pharmaceutical platform changing the future of drug development, delivery, and distribution by powderizing life-saving vaccines and biologics. 

First developed by Princeton scientists during the Covid-19 pandemic, our goal is to give everyone access to the miracles of modern medicine. Our proprietary Rapid Room-Temperature Dehydration (RTAD) platform technology finally solves the global dilemma posed by the thermal stabilization requirements of life-saving heat and freeze-sensitive vaccines and biologics. 

Inaedis is led by its founders: CEO Dr. Maksim Mezhericher and Prof. Howard A. Stone and is backed by Roadrunner Venture Studios and Princeton Innovation Center. 

About Roadrunner Venture Studios:
Roadrunner Venture Studios is a company creation factory. We co-found breakthrough deep-tech ventures with the nation’s most brilliant scientists, engineers, and innovators. Our team gets involved at the earliest possible moment — often when a company is just a whiteboard scribble, a concept modeled in wire-frame, or as founders are puzzling through how to design a pitch deck or process payroll — and rapidly accelerates product development, commercialization, and recruitment. We are the ultimate company “starter-kit,” equipping our portfolio companies with everything they need to go from the kernel of an idea to a venture-backed growth engine. Our promise is clear: our founders leave our studio with a company, a check, a customer, and a team.

Media Contact: Maksim Mezhericher, maksim@inaedis.com

Leave a Reply